Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

KEAP1 protein, human

Known as: Kelch-Like Family Member 19, Kelch-like ECH-associated protein 1, human, KIAA0132 protein, human 
Kelch-like ECH-associated protein 1 (624 aa, ~70 kDa) is encoded by the human KEAP1 gene. This protein is involved in ubiquitin-mediated protein… 
National Institutes of Health

Related topics

Related topics

4 relations
Genes, RegulatorKEAP1 geneUbiquitination

Broader (1)

Kelch-Like ECH-Associated Protein 1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2‐Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma
Nuclear factor erythroid 2‐like 2 (NFE2L2) encodes Nrf2, transcription factor of antioxidative genes. In the presence of reactive… 
2017
2017
Water-Soluble β-cyclodextrin Polymers as Drug Carriers to Improve Solubility, Thermal Stability and Controlled Release of Nifedipine
Two types of water-soluble β-cyclodextrin polymers (β-CD-ECH polymer) were prepared by polymerization of β-cyclodextrin (β-CD… 
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2011
Highly Cited
2011
Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
Resistance to platinum-based chemotherapy develops in the majority of patients with epithelial ovarian cancer (EOC). Platinum… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2011
Highly Cited
2011
LOV KELCH PROTEIN2 and ZEITLUPE repress Arabidopsis photoperiodic flowering under non-inductive conditions, dependent on FLAVIN-BINDING KELCH REPEAT F-BOX1.
LOV KELCH PROTEIN2 (LKP2), ZEITLUPE (ZTL)/LOV KELCH PROTEIN1 (LKP1) and FLAVIN-BINDING KELCH REPEAT F-BOX1 (FKF1) constitute a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE